GPRE vs REX vs ANDE vs BIOX vs AVA

For growth investors, Avista Corporation (AVA) is the stronger pick with 1.

3% revenue growth year-over-year, versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). Avista Corporation (AVA) offers the better valuation at 17. 2x trailing P/E (16. 0x forward), making it the more compelling value choice. Analysts rate Green Plains Inc. (GPRE) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Avista Corporation (AVA) is the cheapest at 17.

2x versus REX American Resources Corporation at 29. 5x. On forward P/E, The Andersons, Inc. is actually cheaper at 14. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Andersons, Inc. wins at 0. 22x versus Avista Corporation's 3. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.

0%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: REX returned +464. 7% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Avista Corporation (AVA) is the lower-risk stock at -0.

00β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately -64657% more volatile than AVA relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 125% for Avista Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Avista Corporation (AVA) is pulling ahead at 1.

3% versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). On earnings-per-share growth, the picture is similar: Avista Corporation grew EPS 4. 4% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, AVA leads at 4. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Avista Corporation (AVA) is the more profitable company, earning 9.

8% net margin versus -15. 5% for Bioceres Crop Solutions Corp. — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVA leads at 18. 0% versus -4. 0% for GPRE. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, The Andersons, Inc. (ANDE) is the more undervalued stock at a PEG of 0. 22x versus Avista Corporation's 3. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Andersons, Inc. (ANDE) trades at 14. 5x forward P/E versus 62. 8x for REX American Resources Corporation — 48. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REX: 23. 3% to $60. 00.

In this comparison, AVA (4.

8% yield), ANDE (1. 1% yield) pay a dividend. GPRE, REX, BIOX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Avista Corporation (AVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

00), 4. 8% yield). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AVA: +40. 1%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (GPRE (Basic Materials) and REX (Basic Materials) and ANDE (Consumer Defensive) and BIOX (Basic Materials) and AVA (Utilities)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: GPRE is a small-cap quality compounder stock; REX is a small-cap quality compounder stock; ANDE is a small-cap quality compounder stock; BIOX is a small-cap quality compounder stock; AVA is a small-cap deep-value stock. ANDE, AVA pay a dividend while GPRE, REX, BIOX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.